299 related articles for article (PubMed ID: 23382385)
1. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.
Hong L; Kenney SR; Phillips GK; Simpson D; Schroeder CE; Nöth J; Romero E; Swanson S; Waller A; Strouse JJ; Carter M; Chigaev A; Ursu O; Oprea T; Hjelle B; Golden JE; Aubé J; Hudson LG; Buranda T; Sklar LA; Wandinger-Ness A
J Biol Chem; 2013 Mar; 288(12):8531-8543. PubMed ID: 23382385
[TBL] [Abstract][Full Text] [Related]
2. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
[TBL] [Abstract][Full Text] [Related]
3. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
[TBL] [Abstract][Full Text] [Related]
4. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
6. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
7. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.
Friesland A; Zhao Y; Chen YH; Wang L; Zhou H; Lu Q
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1261-6. PubMed ID: 23284167
[TBL] [Abstract][Full Text] [Related]
8. RhoG signals in parallel with Rac1 and Cdc42.
Wennerberg K; Ellerbroek SM; Liu RY; Karnoub AE; Burridge K; Der CJ
J Biol Chem; 2002 Dec; 277(49):47810-7. PubMed ID: 12376551
[TBL] [Abstract][Full Text] [Related]
9. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
10. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
Huang Q; Shen HM; Ong CN
Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
[TBL] [Abstract][Full Text] [Related]
11. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.
Aguilar BJ; Zhao Y; Zhou H; Huo S; Chen YH; Lu Q
Cancer Biol Ther; 2019; 20(6):740-749. PubMed ID: 30849276
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
14. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.
Liu Y; Dou Y; Yan L; Yang X; He B; Kong L; Smith W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578854
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells.
Zamudio-Meza H; Castillo-Alvarez A; González-Bonilla C; Meza I
J Gen Virol; 2009 Dec; 90(Pt 12):2902-2911. PubMed ID: 19710257
[TBL] [Abstract][Full Text] [Related]
16. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer.
Ntantie E; Fletcher J; Amissah F; Salako OO; Nkembo AT; Poku RA; Ikpatt FO; Lamango NS
Oncotarget; 2017 May; 8(19):31726-31744. PubMed ID: 28423648
[TBL] [Abstract][Full Text] [Related]
17. Regulation of platelet Rac1 and Cdc42 activation through interaction with calmodulin.
Elsaraj SM; Bhullar RP
Biochim Biophys Acta; 2008 May; 1783(5):770-8. PubMed ID: 18328269
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity.
Yeh YC; Wang CZ; Tang MJ
J Cell Physiol; 2009 Jan; 218(1):146-56. PubMed ID: 18780290
[TBL] [Abstract][Full Text] [Related]
19. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts.
Yang L; Wang L; Zheng Y
Mol Biol Cell; 2006 Nov; 17(11):4675-85. PubMed ID: 16914516
[TBL] [Abstract][Full Text] [Related]
20. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.
Weernink PA; Meletiadis K; Hommeltenberg S; Hinz M; Ishihara H; Schmidt M; Jakobs KH
J Biol Chem; 2004 Feb; 279(9):7840-9. PubMed ID: 14681219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
